Anlon Healthcare Jumps on Developing Two New Anti-Malarial Drugs
Mumbai, September 22 (Udaipur Kiran News): Shares of Anlon Healthcare Ltd surged on the BSE after the company announced the successful development of two new anti-malarial products — Artemether and Lumefantrine. The stock was trading at ₹142.93, up ₹8.50 or 6.32% from its previous close of ₹134.43. The scrip opened at ₹136.70 and touched an … Read more